Clinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance study

BACKGROUND: Drug-induced interstitial lung disease (ILD) is one of the most serious adverse reactions associated with the molecularly targeted drugs. Panitumumab has been approved for advanced or recurrent colorectal cancer. Although there were no adverse reaction reports of ILD in panitumumab monot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Clin Oncol
Main Authors: Osawa, Masahiro, Kudoh, Shoji, Sakai, Fumikazu, Endo, Masahiro, Hamaguchi, Tetsuya, Ogino, Yumiko, Yoneoka, Miyo, Sakaguchi, Motonobu, Nishimoto, Hiroyuki, Gemma, Akihiko
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Japan 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4666285/
https://ncbi.nlm.nih.gov/pubmed/25967287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-015-0834-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados